Surgical Modification of Motor Circuitry

Deep Brain Stimulation, DBS

The only surgical methods approved for treatment of PD involve using lesion therapy (Vitek et al., 2003) or electrical stimulation techniques (deep brain stimulation (Deutchl et al., 2006)), both of which act to ameliorate the pathological neural activity that occurs in PD. This aberrant activity arises from the disruption of the normal balance of excitatory and inhibitory regulation in the basal ganglia after the loss of nigrostriatal dopaminergic neurons. These surgical therapies are, in general, effective against the same types of motor symptoms that can be treated with pharmaceutical dopamine replacement therapies.

Lesion therapy, i.e., thalamotomy and pallidotomy, represent some of the earliest attempts to counteract the disruption of basal ganglia circuitry in PD. These procedures show efficacy in treating PD motor symptoms.

Image from NINDS, NIHImage from NINDS, NIHDeep brain stimulation (DBS) can be effective at treating a number of motor symptoms of Parkinson's disease, and has the great advantage over lesion techniques of being adjustable and essentially reversible. DBS involves placement of stimulating electrodes in specific nuclei of the basal ganglia to reset the motor circuit affected in PD. Target areas for DBS include the internal segment of the globus pallidus and the subthalamic nucleus (Stefani et al., 2007). A number of PD symptoms, such as postural instability and gait disturbances, remain untreated by DBS. Recent studies have investigated whether DBS to the pedunculopontine nucleus (PPN) may be effective as a treatment for postural instability and gait disturbances. DBS to the thalamus has also been used to treat tremor. At this time, the mechanism through which DBS works remains unknown.

23 Jun 2009 09:54 PM EST
Deep brain stimulation of the subthalamic nucleus can, in some patients and in some conditions, induce or worsen cognitive deficits, including impulsivity, executive dysfunction, and psychiatric ... 
Cognitive Symptoms
10 Feb 2010
There is increasing evidence for the hypothesis that Parkinson’s disease (PD) and antiparkinsonian treatments both alter serotonin levels in non-motor areas of the brain which may in turn ... 
12 Jan 2010
Aims: Depth recordings from the basal ganglia of Parkinson patients and dystonic patients have revealed exaggerated local field potential (LFP) activity at alpha (α), beta (β) and gamma ... 
04 Jan 2010
Non motor effects of pedunculopontine nucleus stimulation ... 
11 Jun 2009
Brief Description:This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to design and ... 
WASHINGTON — The Food and Drug Administration said Wednesday a nerve stimulating implant from Medtronic failed to significantly reduce seizures in epilepsy patients. ... 
10 Mar 2010
The Parkinson’s Disease Society has awarded Dr Geert Verheyden from the School of Health Sciences at Southampton General Hospital, an Innovation Grant of nearly £34,000, to investigate ... 
09 Feb 2010
Drs. Karl Deisseroth and Jamie Eberling discuss a new approach to studying parkinsonian disease circuitry. Dr. Deisseroth is developing optical neuroengineering approaches to dissect neural ... 
07 Aug 2009
31 May 2009
Parkinsons' disease is one of the most disabling chronic neurological diseases. It can be treated sufficiently until motor complications with fluctuations of mobility and dyskinesias develop. The ... 
31 May 2009
The purpose of this study is to assess the effects of unilateral deep brain stimulation on upper and lower extremity motor function in advanced Parkinson's disease patients. It is ... 
31 May 2009
The purpose of this trial is to study the mood and cognitive effects of deep brain stimulation in Parkinson's disease. ...